Regen BioPharma Inc (RGBP) Liabilities and Shareholders Equity (2013 - 2025)
Regen BioPharma (RGBP) posted Liabilities and Shareholders Equity of $237,076 for fiscal Q1 2026 (quarter ended Dec 31, 2025), up 23.9% from $191,416 a year earlier but down 13.7% from the prior quarter.
Powered by 
Analysis
Regen BioPharma Inc (RGBP) Liabilities and Shareholders Equity (2013 - 2025) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Regen BioPharma's Liabilities and Shareholders Equity came in at $274,628, up 70.5% from FY2024.
- Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 17.4% (FY2020 to FY2025).
- In prior fiscal years, Regen BioPharma's Liabilities and Shareholders Equity was $161,084 in FY2024 (-54.4%), $353,617 in FY2023 (-36.7%), $559,002 in FY2022 (-53.9%) and $1.21 million in FY2021 (+883.9%).
- Quarterly Liabilities and Shareholders Equity has run from a low of $140,770 in fiscal Q2 2024 to a high of $1.43 million in fiscal Q3 2021 over five years.
- On a year-over-year basis, Liabilities and Shareholders Equity has increased in each of the last five quarters, with an average decline of 1.2% over the last eight quarters.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was fiscal Q4 2021, with growth of 883.9%; the weakest was fiscal Q2 2024, with a decline of 65.4%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior fiscal quarters was $274,628 (Q4 2025), $196,841 (Q3 2025) and $169,482 (Q2 2025).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 237,076.00 |
| Sep 30, 2025 | 274,628.00 |
| Jun 30, 2025 | 196,841.00 |
| Mar 31, 2025 | 169,482.00 |
| Dec 31, 2024 | 191,416.00 |
| Sep 30, 2024 | 161,084.00 |
| Jun 30, 2024 | 170,150.00 |
| Mar 31, 2024 | 140,770.00 |
| Dec 31, 2023 | 159,528.00 |
| Sep 30, 2023 | 353,617.00 |
| Jun 30, 2023 | 285,196.00 |
| Mar 31, 2023 | 406,635.00 |
| Dec 31, 2022 | 414,108.00 |
| Sep 30, 2022 | 559,002.00 |
| Jun 30, 2022 | 689,693.00 |
| Mar 31, 2022 | 630,869.00 |
| Dec 31, 2021 | 735,241.00 |
| Sep 30, 2021 | 1.21 Mn |
| Jun 30, 2021 | 1.43 Mn |
| Mar 31, 2021 | 178,015.00 |
API Access
Regen BioPharma Inc Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RGBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "RGBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RGBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();